US Stock MarketDetailed Quotes

APLT Applied Therapeutics

Watchlist
  • 9.625
  • +0.355+3.83%
Close Nov 22 16:00 ET
  • 9.490
  • -0.135-1.40%
Post 20:01 ET
1.12BMarket Cap-6778P/E (TTM)

Applied Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
122K
144K
-98.22%190K
9.99M
-667K
0
0
10.66M
0
0
Operating revenue
--122K
--144K
-98.22%190K
--9.99M
---667K
--0
--0
--10.66M
--0
--0
Cost of revenue
Gross profit
Operating expense
92.74%29.87M
19.84%20.58M
-1.09%21.28M
-10.15%74.53M
7.22%20.34M
-19.95%15.5M
-20.19%17.18M
-6.85%21.52M
-21.46%82.95M
-30.03%18.97M
Selling and administrative expenses
219.26%15.04M
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
-24.52%4.71M
-13.58%5.29M
-30.83%5.58M
-36.55%27.32M
-39.60%6.88M
-General and administrative expense
219.26%15.04M
99.89%10.58M
62.39%9.07M
-24.50%20.62M
-26.77%5.04M
-24.52%4.71M
-13.58%5.29M
-30.83%5.58M
-36.55%27.32M
-39.60%6.88M
Research and development costs
37.49%14.83M
-15.81%10M
-23.33%12.22M
-3.11%53.91M
26.55%15.3M
-17.77%10.79M
-22.82%11.88M
6.02%15.94M
-11.09%55.63M
-23.10%12.09M
Operating profit
-91.95%-29.74M
-19.00%-20.44M
-94.26%-21.09M
22.20%-64.54M
-10.73%-21.01M
19.95%-15.5M
20.19%-17.18M
53.00%-10.86M
21.46%-82.95M
30.03%-18.97M
Net non-operating interest income expense
246.17%1.36M
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
72.69%392K
267.57%408K
190.79%221K
23.42%685K
15.81%271K
Non-operating interest income
246.17%1.36M
53.92%628K
165.16%586K
100.29%1.37M
29.89%352K
72.69%392K
267.57%408K
190.79%221K
--685K
--271K
Other net income (expense)
-47.45%-40.21M
277.30%22.71M
-12,786.20%-63.43M
-23,192.18%-56.6M
-498.48%-17.02M
-97,482.14%-27.27M
-188.04%-12.81M
620.83%500K
53.36%-243K
1,631.18%4.27M
Gain on sale of security
-47.32%-40.18M
277.63%22.74M
-13,619.19%-63.41M
-85,616.67%-56.57M
-498.64%-16.96M
-75,869.44%-27.28M
-193.87%-12.8M
--469K
---66K
--4.26M
Other non- operating income (expenses)
-310.00%-21K
-580.00%-34K
-183.87%-26K
84.75%-27K
-458.82%-61K
225.00%10K
94.44%-5K
132.29%31K
66.03%-177K
106.09%17K
Income before tax
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Income tax
Net income
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Net income continuous Operations
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Minority interest income
Net income attributable to the parent company
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-61.89%-68.59M
109.80%2.9M
-728.04%-83.94M
-45.15%-119.76M
-161.13%-37.68M
-121.82%-42.37M
-14.39%-29.58M
56.16%-10.14M
21.86%-82.51M
46.87%-14.43M
Basic earnings per share
-2.13%-0.48
105.41%0.02
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
-17.50%-0.47
61.46%-0.37
79.55%-0.18
47.09%-2.18
84.62%-0.16
Diluted earnings per share
-2.13%-0.48
64.86%-0.13
-272.22%-0.67
34.86%-1.42
-106.25%-0.33
-17.50%-0.47
61.46%-0.37
79.55%-0.18
47.09%-2.18
84.62%-0.16
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 122K144K-98.22%190K9.99M-667K0010.66M00
Operating revenue --122K--144K-98.22%190K--9.99M---667K--0--0--10.66M--0--0
Cost of revenue
Gross profit
Operating expense 92.74%29.87M19.84%20.58M-1.09%21.28M-10.15%74.53M7.22%20.34M-19.95%15.5M-20.19%17.18M-6.85%21.52M-21.46%82.95M-30.03%18.97M
Selling and administrative expenses 219.26%15.04M99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M-24.52%4.71M-13.58%5.29M-30.83%5.58M-36.55%27.32M-39.60%6.88M
-General and administrative expense 219.26%15.04M99.89%10.58M62.39%9.07M-24.50%20.62M-26.77%5.04M-24.52%4.71M-13.58%5.29M-30.83%5.58M-36.55%27.32M-39.60%6.88M
Research and development costs 37.49%14.83M-15.81%10M-23.33%12.22M-3.11%53.91M26.55%15.3M-17.77%10.79M-22.82%11.88M6.02%15.94M-11.09%55.63M-23.10%12.09M
Operating profit -91.95%-29.74M-19.00%-20.44M-94.26%-21.09M22.20%-64.54M-10.73%-21.01M19.95%-15.5M20.19%-17.18M53.00%-10.86M21.46%-82.95M30.03%-18.97M
Net non-operating interest income expense 246.17%1.36M53.92%628K165.16%586K100.29%1.37M29.89%352K72.69%392K267.57%408K190.79%221K23.42%685K15.81%271K
Non-operating interest income 246.17%1.36M53.92%628K165.16%586K100.29%1.37M29.89%352K72.69%392K267.57%408K190.79%221K--685K--271K
Other net income (expense) -47.45%-40.21M277.30%22.71M-12,786.20%-63.43M-23,192.18%-56.6M-498.48%-17.02M-97,482.14%-27.27M-188.04%-12.81M620.83%500K53.36%-243K1,631.18%4.27M
Gain on sale of security -47.32%-40.18M277.63%22.74M-13,619.19%-63.41M-85,616.67%-56.57M-498.64%-16.96M-75,869.44%-27.28M-193.87%-12.8M--469K---66K--4.26M
Other non- operating income (expenses) -310.00%-21K-580.00%-34K-183.87%-26K84.75%-27K-458.82%-61K225.00%10K94.44%-5K132.29%31K66.03%-177K106.09%17K
Income before tax -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Income tax
Net income -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Net income continuous Operations -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Minority interest income
Net income attributable to the parent company -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -61.89%-68.59M109.80%2.9M-728.04%-83.94M-45.15%-119.76M-161.13%-37.68M-121.82%-42.37M-14.39%-29.58M56.16%-10.14M21.86%-82.51M46.87%-14.43M
Basic earnings per share -2.13%-0.48105.41%0.02-272.22%-0.6734.86%-1.42-106.25%-0.33-17.50%-0.4761.46%-0.3779.55%-0.1847.09%-2.1884.62%-0.16
Diluted earnings per share -2.13%-0.4864.86%-0.13-272.22%-0.6734.86%-1.42-106.25%-0.33-17.50%-0.4761.46%-0.3779.55%-0.1847.09%-2.1884.62%-0.16
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data